AASHNA FAIZY: Open Payments
NPI 1154882587 · GLOUCESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 83 payments from 16 companies in 2025. Trend: 2023 $1,913 · 2024 $1,663 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $298 |
| Janssen Biotech, Inc. | 15 | $173 |
| Novartis Pharmaceuticals Corporation | 9 | $166 |
| Amgen Inc. | 7 | $157 |
| Regeneron Healthcare Solutions, Inc. | 6 | $150 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $135 |
| E.R. Squibb & Sons, L.L.C. | 5 | $90 |
| UCB, Inc. | 3 | $87 |
| GENZYME CORPORATION | 3 | $79 |
| LEO Pharma Inc. | 2 | $55 |
Products named: DUPIXENT, TREMFYA, OTEZLA, RINVOQ, SKYRIZI, ILUMYA, COSENTYX, Sotyktu.
Industry payments across VA — which companies pay providers there.
